Home Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies
Article
Licensed
Unlicensed Requires Authentication

Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies

  • Lisa Rockenbauer , Beate Eichelberger and Simon Panzer EMAIL logo
Published/Copyright: March 14, 2015

Abstract

Background: The identification of platelet alloantibodies is indispensible for the diagnoses of fetal/neonatal alloimmune thrombocytopenia and refractoriness to platelet transfusions.

Methods: We compared the results obtained with the gold-standard assay for the detection and specification of platelet antibodies, the monoclonal antibody-specific immobilization of platelet antigen assay (MAIPA), with those from two bead-based assays, simultaneous analysis of specific platelet antibodies assay (SASPA), and the recently commercialized bead-based assay Pak Lx.

Results: For the detection of alloantibodies by SASPA, the sensitivity was 94.6%, the specificity was 99.5% The respective results for Pak Lx were 98% and 99.8%. Some antibody specificities were revealed by SASPA or Pak Lx but not by MAIPA. However, there were also antibodies detected by MAIPA that were not seen by SASPA or Pak Lx. Antibody dilution experiments suggest that SASPA or Pak Lx are more sensitive than MAIPA.

Conclusions: All three assays have limitations, but Pak Lx is suited for screening. However, other assays are necessary if results are not conclusive or for evaluations beyond the commercial assay’s design.


Corresponding author: Simon Panzer, MD, Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria, Phone: +43 1 40400 53200, Fax: +43 1 40400 53210, E-mail:

Acknowledgments

Part of this work was the diploma thesis of L.R. Pak Lx was generously provided by Immucor, Germany.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol 2013;161:3–14.10.1111/bjh.12235Search in Google Scholar PubMed PubMed Central

2. Heikal NM, Smock KJ. Laboratory testing for platelet antibodies. Am J Hematol 2013;88:818–21.10.1002/ajh.23503Search in Google Scholar PubMed

3. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005;105:4106–14.10.1182/blood-2003-08-2724Search in Google Scholar PubMed PubMed Central

4. Kiefel V, Santoso S, Weisheit M, Müeller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722–6.10.1182/blood.V70.6.1722.1722Search in Google Scholar

5. Kiefel V. The MAIPA assay and its applications in immunohaematology. Transfus Med 1992;2:181–8.10.1111/j.1365-3148.1992.tb00153.xSearch in Google Scholar PubMed

6. Kaplan C, Freedman J, Foxcroft Z, Husebekk A, Metcalfe P, Muniz-Diaz E, et al. International Society of Blood Transfusion – Working Party on Platelet Immunology. Monoclonal platelet antigen capture assays (MAIPA) and reagents: a statement. Vox Sang 2007;93:298–9.10.1111/j.1423-0410.2007.00943.xSearch in Google Scholar PubMed

7. Nguyen XD, Dugrillon A, Beck C, Kerowgan M, Klüter H. A novel method for simultaneous analysis of specific platelet antibodies: SASPA. Br J Haematol 2004;127:552–60.10.1111/j.1365-2141.2004.05233.xSearch in Google Scholar PubMed

8. Fujiwara K, Shimano K, Tanaka H, Sekine M, Kashiwase K, Uchikawa M, et al. Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sang 2009;96:244–51.10.1111/j.1423-0410.2008.01140.xSearch in Google Scholar PubMed

9. Porcelijn L, Huiskes E, Comijs-van Osselen I, Chhatta A, Rathore V, Meyers M. A new bead-based human platelet antigen antibodies detection assay vs. the monoclonal antibody immobilization of platelet antigens assay. Transfusion 2014;54:1486–92.10.1111/trf.12509Search in Google Scholar PubMed

10. Nguyen XD, Goebel M, Schober M, Klüter H, Panzer S. The detection of platelet antibodies by simultaneous analysis of specific platelet antibodies and the monoclonal antibody-specific immobilization of platelet antigens: an interlaboratory comparison. Transfusion 2010;50:1429–34.10.1111/j.1537-2995.2010.02610.xSearch in Google Scholar PubMed

11. Kurz M, Knöbl P, Kalhs P, Greinix HT, Höcker P, Panzer S. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Transfusion 2001;41:771–4.10.1046/j.1537-2995.2001.41060771.xSearch in Google Scholar PubMed

12. Socher I, Zwingel C, Santoso S, Kroll H. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes. Transfusion 2008;48:463–72.10.1111/j.1537-2995.2007.01550.xSearch in Google Scholar PubMed

13. Brand A, van Leeuwen A, Eernisse JG, van Rood JJ. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood 1978;51:781–8.10.1182/blood.V51.5.781.781Search in Google Scholar

Received: 2014-10-22
Accepted: 2015-2-17
Published Online: 2015-3-14
Published in Print: 2015-10-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it
  4. The standardization of the urine albumin assays: no longer deferrable
  5. Reviews
  6. The role of telomeres and vitamin D in cellular aging and age-related diseases
  7. Atypical hemolytic uremic syndrome: from diagnosis to treatment
  8. Clinical relevance and contemporary methods for counting blood cells in body fluids suspected of inflammatory disease
  9. EFLM Opinion Paper
  10. How to assess the quality of your analytical method?
  11. Genetics and Molecular Diagnostics
  12. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay
  13. General Clinical Chemistry and Laboratory Medicine
  14. Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data
  15. A study examining the bias of albumin and albumin/creatinine ratio measurements in urine
  16. National survey on appropriateness of clinical biochemistry reporting in China
  17. Potentiometric measurement of urinary iodine concentration in patients with thyroid diseases with and without previous exposure to non-radioactive iodine
  18. Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange Program
  19. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis
  20. Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies
  21. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty
  22. Whole blood thromboelastometry profiles in women with preeclampsia
  23. Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis
  24. Reference Values and Biological Variations
  25. Reference ranges of serum bile acids in children and adolescents
  26. Infectious Diseases
  27. Elevated circulating ghrelin, but not peptide YY(3-36) levels, in term neonates with infection
  28. Cardiovascular Diseases
  29. Head-to-head comparison of 10 natriuretic peptide assays
  30. Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors
  31. Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death
  32. Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins
  33. A new formula for estimation of low-density lipoprotein cholesterol in an ethnic Chinese population
  34. Letter to the Editors
  35. Laboratory medicine: let’s say it is the mirror of science (and medicine)
  36. The economic burden of hemolysis
  37. Acute effects of conventional and extended hemodialysis and hemodiafiltration on high-sensitivity cardiac troponins
  38. Cuvette carryover with the gentamicin assay on the Beckman AU480 analyser
  39. Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases
  40. Automated alkaline-pH electrophoresis followed by densitometry does not correlate with cation-exchange (CE)-HPLC in quantification of HbA2 and variant hemoglobins
  41. Progression from light chain myeloma to secondary plasma cell leukemia accompanied by peripheral blood eosinophilia
  42. Harmonization of results has not been fully achieved for serum immunoglobulin measurements
  43. The risk of macrovascular complications in subjects genotyped for common IL-6 gene and TNF-α gene variants
  44. Comparison of nucleated red blood cell count with four commercial hematological analyzers
  45. Reply to: The risk of macrovascular complications in subjects genotyped for common IL-6 gene and TNF-α gene variants
  46. Congress Abstracts
  47. Congress of Clinical Chemistry and Laboratory Medicine
  48. 47th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
  49. 15th EFLM Continuous Postgraduate Course in Clinical Chemistry and Laboratory Medicine
Downloaded on 6.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-1037/html
Scroll to top button